Titre : Rites funéraires

Rites funéraires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Triglycerides
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Rites funéraires : Questions médicales les plus fréquentes", "headline": "Rites funéraires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Rites funéraires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-27", "dateModified": "2025-03-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Rites funéraires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Anthropologie culturelle", "url": "https://questionsmedicales.fr/mesh/D000884", "about": { "@type": "MedicalCondition", "name": "Anthropologie culturelle", "code": { "@type": "MedicalCode", "code": "D000884", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Funérailles", "alternateName": "Burial", "url": "https://questionsmedicales.fr/mesh/D002048", "about": { "@type": "MedicalCondition", "name": "Funérailles", "code": { "@type": "MedicalCode", "code": "D002048", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201.450.550.150" } } }, { "@type": "MedicalWebPage", "name": "Crémation", "alternateName": "Cremation", "url": "https://questionsmedicales.fr/mesh/D055700", "about": { "@type": "MedicalCondition", "name": "Crémation", "code": { "@type": "MedicalCode", "code": "D055700", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201.450.550.175" } } }, { "@type": "MedicalWebPage", "name": "Embaumement", "alternateName": "Embalming", "url": "https://questionsmedicales.fr/mesh/D004615", "about": { "@type": "MedicalCondition", "name": "Embaumement", "code": { "@type": "MedicalCode", "code": "D004615", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201.450.550.250" } } } ], "about": { "@type": "MedicalCondition", "name": "Rites funéraires", "alternateName": "Funeral Rites", "code": { "@type": "MedicalCode", "code": "D005655", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Megumi Kondo-Arita", "url": "https://questionsmedicales.fr/author/Megumi%20Kondo-Arita", "affiliation": { "@type": "Organization", "name": "President's Office, Global Center of Osaka Medical and Pharmaceutical University, Takatsuki, Japan." } }, { "@type": "Person", "name": "Carl B Becker", "url": "https://questionsmedicales.fr/author/Carl%20B%20Becker", "affiliation": { "@type": "Organization", "name": "Policy Science Unit, School of Medicine, Kyoto University, Kyoto, Japan." } }, { "@type": "Person", "name": "Livia Sani", "url": "https://questionsmedicales.fr/author/Livia%20Sani", "affiliation": { "@type": "Organization", "name": "SULISOM UR 3071, Université de Strasbourg, France." } }, { "@type": "Person", "name": "Marie-Frédérique Bacqué", "url": "https://questionsmedicales.fr/author/Marie-Fr%C3%A9d%C3%A9rique%20Bacqu%C3%A9", "affiliation": { "@type": "Organization", "name": "SULISOM UR 3071, Université de Strasbourg, France." } }, { "@type": "Person", "name": "Yozo Taniyama", "url": "https://questionsmedicales.fr/author/Yozo%20Taniyama", "affiliation": { "@type": "Organization", "name": "Department of Religious Studies, Tohoku University, Sendai 980-8576, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The correlation between pseudoexfoliation syndrome and the Triglyceride-Glucose index.", "datePublished": "2022-06-20", "url": "https://questionsmedicales.fr/article/35723782", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00417-022-05737-z" } }, { "@type": "ScholarlyArticle", "name": "The relationship between nondipper hypertension and triglyceride glucose index.", "datePublished": "2022-09-12", "url": "https://questionsmedicales.fr/article/36094366", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBP.0000000000000618" } }, { "@type": "ScholarlyArticle", "name": "The triglycerides-glucose index and the triglycerides to high-density lipoprotein cholesterol ratio are both effective predictors of in-hospital death in non-diabetic patients with AMI.", "datePublished": "2022-11-21", "url": "https://questionsmedicales.fr/article/36438585", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7717/peerj.14346" } }, { "@type": "ScholarlyArticle", "name": "Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease.", "datePublished": "2023-11-03", "url": "https://questionsmedicales.fr/article/37924128", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12944-023-01954-5" } }, { "@type": "ScholarlyArticle", "name": "Sex-Specific Comparison Between Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict New-Onset Hypertension in Middle-Aged and Older Adults.", "datePublished": "2023-09-18", "url": "https://questionsmedicales.fr/article/37721166", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1161/JAHA.123.030022" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Sciences sociales", "item": "https://questionsmedicales.fr/mesh/D012942" }, { "@type": "ListItem", "position": 3, "name": "Anthropologie", "item": "https://questionsmedicales.fr/mesh/D000883" }, { "@type": "ListItem", "position": 4, "name": "Anthropologie culturelle", "item": "https://questionsmedicales.fr/mesh/D000884" }, { "@type": "ListItem", "position": 5, "name": "Rites funéraires", "item": "https://questionsmedicales.fr/mesh/D005655" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Rites funéraires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Rites funéraires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Rites funéraires", "description": "Comment identifier un rite funéraire spécifique ?\nQuels éléments caractérisent un rite funéraire ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Triglycerides&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Rites funéraires", "description": "Quels sentiments peuvent émerger lors d'un rite funéraire ?\nComment le deuil se manifeste-t-il pendant un rite ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Triglycerides&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Rites funéraires", "description": "Comment préparer un rite funéraire à l'avance ?\nQuels documents sont nécessaires pour un rite funéraire ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Triglycerides&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Rites funéraires", "description": "Quels soutiens psychologiques sont offerts lors des rites ?\nComment les rites funéraires aident-ils au processus de deuil ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Triglycerides&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Rites funéraires", "description": "Quelles complications peuvent survenir lors d'un rite ?\nComment gérer les émotions intenses lors d'un rite ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Triglycerides&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Rites funéraires", "description": "Quels facteurs influencent les rites funéraires ?\nComment le contexte social affecte-t-il les rites ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Triglycerides&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un rite funéraire spécifique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par l'analyse des symboles, des pratiques et des croyances culturelles." } }, { "@type": "Question", "name": "Quels éléments caractérisent un rite funéraire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les éléments incluent les rituels, les prières, les offrandes et les cérémonies d'enterrement." } }, { "@type": "Question", "name": "Quels sentiments peuvent émerger lors d'un rite funéraire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les participants peuvent ressentir de la tristesse, de la colère, de la paix ou de la nostalgie." } }, { "@type": "Question", "name": "Comment le deuil se manifeste-t-il pendant un rite ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le deuil peut se manifester par des pleurs, des cris ou des comportements de commémoration." } }, { "@type": "Question", "name": "Comment préparer un rite funéraire à l'avance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de discuter des souhaits avec la famille et de rédiger des directives claires." } }, { "@type": "Question", "name": "Quels documents sont nécessaires pour un rite funéraire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les documents incluent le certificat de décès et les arrangements préalables si existants." } }, { "@type": "Question", "name": "Quels soutiens psychologiques sont offerts lors des rites ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des conseillers ou des thérapeutes peuvent être présents pour aider les endeuillés." } }, { "@type": "Question", "name": "Comment les rites funéraires aident-ils au processus de deuil ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils offrent un cadre pour exprimer la douleur et favoriser la mémoire du défunt." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir lors d'un rite ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des conflits familiaux ou des désaccords sur les rituels peuvent survenir." } }, { "@type": "Question", "name": "Comment gérer les émotions intenses lors d'un rite ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Il est important d'avoir un soutien émotionnel et de permettre l'expression des sentiments." } }, { "@type": "Question", "name": "Quels facteurs influencent les rites funéraires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la culture, la religion, et les traditions familiales." } }, { "@type": "Question", "name": "Comment le contexte social affecte-t-il les rites ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le contexte social peut déterminer la manière dont les rites sont perçus et pratiqués." } } ] } ] }

Sources (3179 au total)

The correlation between pseudoexfoliation syndrome and the Triglyceride-Glucose index.

Pseudoexfoliation (PEX) syndrome is an age-related disease characterized by the accumulation of extracellular material in many ocular structures, skin and internal organs. Recent studies have shown th... In the present study, 50 patients with PEX syndrome who were admitted to the ophthalmology outpatient clinic were evaluated along with 50 others who made up the control group. The Triglyceride-Glucose... The mean age was 68.2 ± 1.2 years and 61.0% of the patients were male. There was no statistically significant difference between the two groups in terms of blood sugar and lipid profile (except trigly... Results showed that the TyG index was high in patients diagnosed with PEX. The risk of vascular diseases can be determined by examining the TyG index in patients with PEX, and this predetermination wo...

The triglycerides-glucose index and the triglycerides to high-density lipoprotein cholesterol ratio are both effective predictors of in-hospital death in non-diabetic patients with AMI.

The triglycerides-glucose index (TyG) and the triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) are simple indicators for assessing insulin resistance in epidemiological studies. We aim... A total of 1,648 AMI patients without diabetes were enrolled from the Department of Cardiology, Zhongda Hospital, between 2012.03 and 2018.12. The medical history, laboratory and imaging data of patie... 1. In AMI group, the TyG index was significantly increased in death groups compared to no-death groups (... TyG index and TG/HDL-C, as emerged simple markers of insulin resistance, were both important predictors of in-hospital death in AMI patients without diabetes....

Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease.

The elevation of TyG is considered an important factor in promoting the progression of non-alcoholic fatty liver disease (NAFLD), but its impact on the degree of liver steatosis remains unclear. This ... From January 2021 to March 2022, 1171 participants underwent health check-ups, and all underwent FibroScan transient elastography. The analysis focused on identifying the factors that contribute to th... The predictive value of TyG-BMI (OR = 1.039, 95% CI 1.031-1.046) in triggering NAFLD development was greater than that of TyG alone. The areas under the curve for TyG-BMI and TyG were calculated at 0.... The TyG-BMI showed higher accuracy in predicting NAFLD than did the TyG, and was more closely linked to the severity of hepatic steatosis. Therefore, it can be included as a parameter in health manage...

Association of triglyceride levels and prostate cancer: a Mendelian randomization study.

The association between triglyceride and prostate cancer (PCa) has been reported in observational studies. However, the causality from triglyceride on PCa remained unknown.... Two-sample Mendelian randomization (MR) was performed with triglyceride genome-wide association study (GWAS) data from 177,861 individuals and GWAS summary statistics of PCa from 463,010 individuals. ... Association for an effect of triglyceride on PCa risk was found in IVW (odds ratio [OR]: 1.002, 95% confidence interval (CI): 1.000-1.004, p = 0.016). However, opposing results were observed using the... The large MR analysis indicated that the potential causal effect of triglyceride on PCa. The odds of PCa would increase with high levels of triglyceride....

Genome-wide discovery for diabetes-dependent triglycerides-associated loci.

We aimed to discover loci associated with triglyceride (TG) levels in the context of type 2 diabetes (T2D). We conducted a genome-wide association study (GWAS) in 424,120 genotyped participants of the... We stratified the cohort based on T2D status and conducted association analyses of TG levels for genetic variants with minor allele count (MAC) at least 20 in each stratum. Effect differences of genet... Among 21,176 T2D and 402,944 non-T2D samples from UKB, stratified GWAS identified 19 and 315 genomic risk loci significantly associated with TG levels, respectively. Only chr6p21.32 exhibited genome-w... In conclusion, we identified an intergenic variant near HLA-DQB1/DQA2 significantly associates with decreased triglycerides only among those with T2D and highlights an immune overlap with T1D....

Association of triglyceride-glucose index with sarcopenia: NHANES 2011-2014.

A newly developed technique, the Triglyceride-glucose (TyG) index, supplies a more straightforward method to identify IR than the HOMA-IR (Homeostasis Model Assessment of Insulin Resistance). Yet no m... Between 2011 to 2014, data from the NHANES were used to conduct a nationally representative study involving 2,504 participants. LMM, LMS, and sarcopenia were the outcome variables. Moreover, this posi... The TyG index revealed a significant correlation with the prevalence of developing LMM (OR = 1.63(1.26-2.11),... Sarcopenia and the TyG index reveal an essential positive link. It highlights the potential utility of the TyG index as a screening tool for identifying individuals at risk of sarcopenia earlier....

Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease.

Despite indisputable role of LDL-C lowering, a considerable residual risk for atherosclerotic cardiovascular disease (ASCVD) persists. The precise mechanism(s) underlying this phenomenon remain unclea... Several long-term observational studies have shown a significant relationship between Rem-C and ASCVD events, compared with other triglyceride-related parameters. Recent trials have shown that lowerin... Elevated Rem-C as a risk determinant, with LDL-C at goal, requires additional studies in clinical trials. Standardization and accuracy of Rem-C assays (calculated versus direct method) is also needed....